Redhill生物製藥 RDHL 深 滬
等待開盤 08-16 09:30:00 美东时间
1.3799
-0.030
-2.13%
華盛通- 最 高1.41
- 今 開1.41
- 成交量 1.20万股
- 最 低 1.3544
- 昨 收 1.41
- 總市值 316.22万
- 52周最高 12.50
- 市盈率 靜 0.01
- 換手率 0.52%
- 52周最低 1.06
- 委 比 -79.59%
- 總股本 229.16万
- 歷史最高 22220.00
- 量 比 0.23
- 振 幅 3.94%
- 歷史最低 1.06
- 每 手 1
- 風險率 9.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多RedHill Biopharma Granted Nasdaq Compliance Extension
RedHill Biopharma ( ($RDHL) ) just unveiled an announcement. On August 8, 2025,...
08-14 19:28
RedHill Biopharma Gains FDA Support for Innovative Crohn’s Disease Therapy
An update from RedHill Biopharma ( ($RDHL) ) is now available. On July 21, 2025...
07-21 21:27
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Telomir Pharmaceuticals (NASDAQ:TELO) shares rose 151.2% to $3.04 duri...
07-18 20:07
Redhill Biopharma has received a decision to grant European patent number EP3359255 titled "COMBINATION THERAPIES FOR TREATING CANCER ".
https://register.epo.org/application?number=EP16853154
07-18 03:59
RedHill Biopharma Announces The Initiation Of Patient Recruitment Into The Phase 2 Study Evaluating The Efficacy Of Opaganib3 In Combination With Darolutamide4 In Men With Metastatic Castrate-Resistant Prostate Cancer
Led by Professor Lisa Horvath, from Sydney's Chris O'Brien Lifehouse, and ANZUP, the innovative 60-participant placebo-controlled randomized study is designed to test the potentially enhancing effect of opaganib in
07-02 00:03
RedHill Biopharma Approves Key Resolutions at Annual Meeting
RedHill Biopharma ( ($RDHL) ) just unveiled an announcement. On May 26, 2025, R...
05-27 19:28
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers CNS Pharma (NASDAQ:CNSP) shares rose 90.1% to $2.3 during Tuesday's pr...
05-13 20:10
RedHill Biopharma Secures South Korean Court Approval For Asset Attachment Following $8.25M Judgment Against Kukbo
Korea's Incheon District Court attachment grant prevents asset disposal by Kukbo prior to enforcement, following the New York Supreme Court's approximately $8.25 million plus legal fees and costs summary judgment in
05-13 19:04
RedHill Biopharma Launches H. Pylori Education Program at Gastroenterology Congress
An update from RedHill Biopharma ( ($RDHL) ) is now available. On May 2, 2025, ...
05-02 19:27
RedHill Biopharma Receives Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency
The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected by receipt of the Notif...
04-18 04:01
